Liposomal Formulation of Ellagic Acid Counteracts Amyloid‐β Oligomer‐Induced Cellular Stress: Influence of Neuronal Differentiation
ChemMedChem · 28.10.2026 · 21 (20)
DOI: 10.1002/cmdc.70546 ↗Kurz gefasst
Fachartikel in der Zeitschrift ChemMedChem, online erschienen am 22.10.2026. Verfasst von Rebecca Castellacci und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chemistry "Ugo Schiff" (DICUS), University of Florence, Florence, Italy. Hauptthemen laut MEDLINE: Ellagic Acid, Amyloid beta-Peptides, Neurons, Neuroprotective Agents. Die Arbeit nennt 64 Literaturangaben. Gefördert von: Università degli Studi di Firenze, Fondi di Ateneo 2025, Università degli Studi di Firenze.
Abstract (Originalsprache)
Ellagic acid (EA) is a polyphenolic compound with antioxidant and neuroprotective properties whose therapeutic application is limited by poor aqueous solubility, low permeability and limited stability. In this study, EA‐loaded liposomes (F2) were developed and characterized to improve its biopharmaceutical properties and evaluate its protective effects against amyloid‐β (Aβ) oligomer‐induced cellular stress. F2 showed favorable physicochemical characteristics, storage stability, and stability in the presence of human serum albumin, while providing sustained EA release. In the BBB‐PAMPA assay, F2 maintained measurable passive EA permeability while allowing higher EA amount permeated. The biological effects of EA and F2 were subsequently evaluated in undifferentiated and retinoic acid‐differentiated SH‐SY5Y cells (RA‐SH‐SY5Y) exposed to Aβ oligomers. In undifferentiated cells, F2 showed a distinct concentration‐dependent protective profile, particularly at 10 μM, associated with preservation of cellular metabolic activity, attenuation of ROS accumulation and partial preservation of mitochondrial‐associated functional and morphological parameters. In RA‐SH‐SY5Y, EA and F2 showed broadly comparable protective effects. Overall, liposomes improved the biopharmaceutical properties of EA while preserving or enhancing its biological activity against Aβ‐induced cellular stress. The differential responses observed in undifferentiated and RA‐SH‐SY5Y cells further suggest that the biological advantage associated with liposomal formulation may be influenced by cellular phenotype.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Chemistry "Ugo Schiff" (DICUS), University of Florence, Florence, Italy.
- Department of Experimental and Clinical Biomedical Sciences, University of Florence, Florence, Italy.
ORCID-Profile: Rebecca Castellacci, Federica Carnemolla, Manuela Leri, Maria Camilla Bergonzi
Förderung
- Università degli Studi di Firenze, Fondi di Ateneo 2025
- Università degli Studi di Firenze
Zitieren
APA
Castellacci, R., Carnemolla, F., Leri, M., Bucciantini, M., & Bergonzi, M. C. (2026). Liposomal Formulation of Ellagic Acid Counteracts Amyloid‐β Oligomer‐Induced Cellular Stress: Influence of Neuronal Differentiation. ChemMedChem, 21(20). https://doi.org/10.1002/cmdc.70546
Vancouver
Castellacci R, Carnemolla F, Leri M, Bucciantini M, Bergonzi MC. Liposomal Formulation of Ellagic Acid Counteracts Amyloid‐β Oligomer‐Induced Cellular Stress: Influence of Neuronal Differentiation. ChemMedChem. 2026;21(20). doi:10.1002/cmdc.70546
BibTeX
@article{Castellacci2026,
author = {Castellacci, Rebecca and Carnemolla, Federica and Leri, Manuela and Bucciantini, Monica and Bergonzi, Maria Camilla},
title = {Liposomal Formulation of Ellagic Acid Counteracts Amyloid‐β Oligomer‐Induced Cellular Stress: Influence of Neuronal Differentiation},
journal = {ChemMedChem},
year = {2026},
volume = {21},
number = {20},
doi = {10.1002/cmdc.70546}
}
EUVIMED